View Future GrowthADM Tronics Unlimited 過去の業績過去 基準チェック /06ADM Tronics Unlimitedは22.7%の年平均成長率で業績を伸ばしているが、Chemicals業界はdecliningで4%毎年増加している。売上は減少しており、年平均0.08%の割合である。主要情報22.72%収益成長率22.72%EPS成長率Chemicals 業界の成長12.93%収益成長率-0.081%株主資本利益率-0.89%ネット・マージン-0.20%前回の決算情報31 Dec 2025最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.お知らせ • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.収支内訳ADM Tronics Unlimited の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:ADMT 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Dec 25301130 Sep 25301130 Jun 25301131 Mar 25301131 Dec 24301130 Sep 24301130 Jun 24301131 Mar 243-11131 Dec 233-11130 Sep 233-11130 Jun 23401131 Mar 23401131 Dec 224-11130 Sep 224-11130 Jun 223-12131 Mar 223-12131 Dec 213-12130 Sep 213-12130 Jun 213-11131 Mar 213-11131 Dec 20301130 Sep 20301130 Jun 20301131 Mar 20301131 Dec 19301130 Sep 19301130 Jun 19301131 Mar 19301131 Dec 18301030 Sep 18301030 Jun 18301031 Mar 18401131 Dec 17401030 Sep 17501030 Jun 17511031 Mar 17511031 Dec 16511030 Sep 16511030 Jun 16512031 Mar 16512031 Dec 15412030 Sep 15412030 Jun 153110質の高い収益: ADMTは現在利益が出ていません。利益率の向上: ADMTは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: ADMTは利益を出していないが、過去 5 年間で年間22.7%の割合で損失を削減してきた。成長の加速: ADMTの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: ADMTは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -1.4% ) と比較することは困難です。株主資本利益率高いROE: ADMTは現在利益が出ていないため、自己資本利益率 ( -0.89% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 18:23終値2026/05/22 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋ADM Tronics Unlimited, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.
お知らせ • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.